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IMPACT OF PHARMACIST INTERVENTION ON THE UTILIZATION OF
TERIPARATIDE IN OSTEOPOROSIS
Lin CC, Tsai SC, Leu WJ, Lin YM
Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan
OBJECTIVES: According to osteoporosis guideline, bisphosphonates are the first
choice of osteoporosis. Alternative treatments include raloxifene, calcitonin,
teriparatide and the last one is least cost-effectiveness. There is strict national
health insurance (NHI) payment rule for teriparatide in Taiwan. If the patient does
notmeet theNHI criteria, this reimbursement paymentwill be cut and hospital has
to pay the fee (several times of NTD$15766). The objective studywas to evaluate the
pharmacist intervention to enhance the utilization of teriparatide and decrease
reimbursement payment cut. METHODS:When physician prescribed teriparatide
initially, the order would send to the regulation system and pharmacists had to
review whether the patient met the criteria. If patient did not meet the criteria,
pharmacistswould inform the physician to change order at next clinic visit. Patient
could receive teriparatide if pass the evaluation vice versa. The data collected from
March 2010 to December 2011. RESULTS: The initial prescription number signifi-
cantly decreased from 51 to 8 per month during March 2010 and December 2011.
The NHI set new payment criteria resulted in the prescription rate declined, par-
ticularly after January 2011. The cut in reimbursement fee of NTD$ 36,2618 in
quarter one of 2010 reduced to zero in quarter three of 2011 since pharmacists
intervened and reviewed the criteria via regulation system before prescribed.
CONCLUSIONS: Pharmacists intervention enhanced the rational use of high cost of
teriparatide and decreased reimbursement payment cut.Pharmacists intervention
enhanced the rational use of high cost of teriparatide and decreased reimburse-
ment payment cut.
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DISPARITIES ON CONGENITAL SYPHILIS IN COLOMBIA FROM 2006 TO 2009
Amaya Arias AC, Peralta Pizza F, Álzate Granados JP, Eslava-Schmalbach J
Universidad Nacional de Colombia, Bogotá, Colombia
OBJECTIVES: To describe disparities in the incidence of diagnosed cases of congen-
ital syphilis by Departments in Colombia between the years 2006-2009.METHODS:
Ecological study. National incidence and incidence by Departments of congenital
syphilis in Colombia were estimated. A descriptive comparison of these ratios
showing the lowest and highest incidence by Departments each year is showed.
Information was obtained form the National Administrative Department of Statis-
tics database. RESULTS: National incidence of congenital syphilis in Colombia in-
creased from 1.98 per 1000 live births in 2006 to 2.56 per 1000 live births in 2009. The
lowest regional incidence in Colombiawas found in Caldaswith 0.35 cases per 1000
live births in 2009. Departmentswith the highest incidence of congenital syphilis in
the same year were Chocó and Meta, with incidences of 7.43 and 5.92 per 1000 live
births, respectively. CONCLUSIONS: Incidence of congenital syphilis has been in-
creasing in Colombia in the last years, and it is far from the goals of the World
Health Organization (0.5 cases per 1000 live births). There are notorious differences
among Departments in Colombia suggesting avoidable disparities in the strategies
for preventing and controlling this disease during pregnancy among them. A crit-
ical review of current programs of public health should be done.
PIH74
DISPARITIES ON MATERNAL MORTALITY AMONG COLOMBIAN REGIONS IN
2000, 2005 AND 2008
Sandoval Vargas G, Amaya AC, Peralta Pizza F, Velasquez D, Eslava Schmalbach JH
Universidad Nacional de Colombia, Bogotá, Colombia
OBJECTIVES: The aim of this ecological study was to describe disparities in mater-
nalmortality by assessing the excess of risk among Colombian regions.METHODS:
We estimated Maternal Mortality Ratios (MMR) for all the departments of Colom-
bia, for all mortality causes and for the years 2000, 2005 and 2008.We described the
main causes ofmaternalmortality in Colombia andwe estimated the excess of risk
by assessing the attributable risk fraction (AF). We compared with the best mater-
nal mortality ratios (MMR) in the world. RESULTS: The estimated MMR ranged
among Colombian regions from 25 to 673 per 100.000 live births. The MMR of the
best country in the world ranged from 2 to 4 per 100.000 live births. In the years
assessed, we found an excess of risk of maternal mortality for all regions over 90%
compared with the world. The main causes of maternal mortality in Colombia
were: other obstetric conditions not classified and hypertensive disorders related
to pregnancy. CONCLUSIONS: There is still a big gap in theMMR among Colombian
regions and betweenColombia comparedwith developed countries. These findings
show persistent inequities in maternal mortality in Colombia given that these
deaths are unnecessary, avoidable and unfair. Re-evaluation of current programs
of safe motherhood and/or new health policies and strategies are requested to
reduce these inequities.
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Velásquez Granados D, Peralta Pizza F, Amaya Arias AC, Eslava Schmalbach JH
Universidad Nacional de Colombia, Bogotá, Colombia
OBJECTIVES: To describe disparities in neonatal mortality rates among Colombian
regions between 2000 and 2009. METHODS: Ecological study. Early, late and total
neonatal mortality rates by Departments in Colombia were estimated from 2000 to
2009. The main causes of neonatal deaths in 2005 were tabulated. The risk excess
was estimated using the attributable fraction, comparing the Departments rates
with the country with the lowest mortality rate in the world for the same year.
Profiles of death causes were compared between Colombia and the country of
reference. Information was obtained from the National Department of Statistics.
RESULTS: The estimated cumulative rate of neonatal mortality in Colombia from
2000 to 2009 was 10.2 deaths per 1000 live births. The worst department had 16
times the mortality rate of the best country in the world. Attributable fractions for
all departments exceeded 78% in all cases. The neonatal mortality rate decreased
by 39% during the study period. Chocó had the lowest decrease during the period
(9%), and the highest decrease was observed in Caquetá (61%). The main causes of
early neonatal mortality were respiratory disorders, followed by obstetric compli-
cations and congenital malformations. CONCLUSIONS: Even though neonatal
mortality rates decreased during the study period, the risk excess observed was
very high when an external point of reference was used. Differences in neonatal
mortality rates within the Country showed an increasing gap between Depart-
ments during the study period. Some of these disparities foundwere avoidable and
suggest disparities in the quality and access to safe motherhood and early infancy
programs within the country, that should be evaluated.
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CLINICAL, HUMANISTIC, AND ECONOMIC BURDEN OF MENSTRUAL SYMPTOMS
IN JAPANESE WOMEN
Wang ECY, Fujimoto N, Watanabe M, Ogawa E, Hayakawa M
Bayer Yakuhin, Ltd., Tokyo, Japan
OBJECTIVES: The study aims at gaining a clear picture of the clinical, humanistic,
and economic burden on women’s daily living caused by menstrual symptoms,
especially pain and bleeding. METHODS: An online survey was conducted in two
phases, with sampling structured to approximate the age and geographic distribu-
tion of women between the ages of 15 to 49. The first survey (n 21,477) investi-
gated retrospectively the conditions associated with menses, and impact on work
and productivity within the previous three months. ‘Menses-related conditions’ in
this research referred to 6 domains from the Menstrual Distress Questionnaire
(MDQ©). The second survey analyzed the difference betweenwomen seekingmed-
ical care (n274) and those not seeking care (n500), with details such as costs,
reasons for seeking care, medications, and treatment satisfaction. RESULTS: The
first survey analyzed 19,254 female with menses (90% of total). Of those, 1.9%
reported seeking medical care within the last 3 months, 18.5% 3 months prior,
and 79.6% reported no visits. 79% reporting any medical contact had received pre-
scription drugs. Of the total sample, 36% were taking OTC medication, 17% expe-
rienced impact on work (absence or lost productivity). About half of those not
seeking care selected ‘unnecessary’ as the reason, however, 70% of this group also
reported inhibition/ limitation of daily life. About 20% reported ‘resistance/dislike’
as reason for not seeking care. MDQ© scorewas strongly correlated tomedical visit
and impact on work. Extrapolated total annual economic burden amounted to 682
billion yen (direct and indirect costs, 8.88 billion USD). CONCLUSIONS: These
findings are similar to a large study conducted ten years ago, suggesting that there
has been no change in treatment, medication, and patient behavior in dealing with
menstrual-related problems. The burden remains large, and those not seeking care
perhaps did not recognize this to be a condition warranting medical help.
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OBJECTIVES: There are multiple drug options for the treatment of epilepsy. Some
patientsmay be refractory to treatment and require combination antiepileptic drug
(AED) treatment. We compared healthcare utilization of refractory and stable epi-
lepsy patients.METHODS: Using a claims database covering 2007-2009, we identi-
fied adults (age18years) with epilepsy who were either stable on therapy (no
change in AED over 12 months) or were refractory (defined as adding AED therapy
to an existing regimen). An index date in 2008 was selected: the date on which an
additional AED was started for refractory patients; and a convenience date for
stable patients. All pharmacy andmedical claims in the post-index year were used
to estimate overall utilization. Claims with epilepsy in any diagnosis field were
used to estimate epilepsy-related utilization. Logistic regressionmodels were used
to adjust for baseline differences. RESULTS: There were 1536 refractory and 8571
stable patients (age: 41.8 vs. 43years; 50.7% vs. 47.6% female; mean Charlson co-
morbidity index: 0.7 vs. 0.5). Refractory patients were hospitalizedmore often than
stable patients, both for any diagnosis (18.3% vs. 9.8% had 1 hospitalization) and
for epilepsy-related diagnoses (15.7% vs. 7%). Refractory patients had greatermean
hospital length of stay (any diagnosis: 10.9 vs. 7.1 and epilepsy-related: 8.9 vs. 5.6
days). They also had more physician office visits than stable patients (any diagno-
sis: 12 vs. 9 and epilepsy-related: 3.6 vs. 2.2). After adjusting for demographics,
region, usual-care physician specialty, and risk factors, the odds of hospitalization
(OR:1.8; 95% CI:1.6-2.1), emergency department visit (OR:1.6; CI:1.5-1.8), epilepsy-
related hospitalization (OR:2.2; CI:1.9-2.6), and epilepsy-related emergency depart-
ment visit (OR:1.9; CI:1.7-2.2) were greater in the refractory group. CONCLUSIONS:
Patients with refractory epilepsy use significantly more health care services than
those with stable disease. As new and more effective AEDs become available, it
may be possible to reduce utilization in the refractory group.
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EFFECT OF HOSPITAL WASTES ON DRINKING WATER QUALITY OF KPK
HOSPITALS PAKISTAN
Bibi Saima Zeb BSZ, Saira Azhar DSA, Qaisar Mahmood QM
COMSAT Abbottabad, Abbottabad, KPK, Pakistan
OBJECTIVES: Evaluating the effect of hospital wastes on drinking water quality of
KPK hospitals and in Pakistan. METHODS: The study was carried out to in Ayub
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